No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals
Established in 2005 and headquartered in Tokyo, Japan, Mitsubishi Chemical Group Corporation operates globally, offering a vast array of products and specialized services. The company's diverse portfolio includes advanced performance materials, fundamental chemicals, industrial gases, and a comprehensive suite of healthcare solutions. Its performance materials segment features specialty chemicals, functional food ingredients, inorganic compounds, electronic and electrical components, molded and processed goods, various films and sheets, synthetic and carbon fibers, alongside a wide range of equipment and systems. This division also provides materials for industrial applications, construction, civil engineering, and water-related projects, as well as consumer goods for leisure, sports, and everyday use. Within the healthcare sector, the corporation delivers pharmaceuticals, drug formulation substances, and innovative drug discovery solutions. It also supplies diagnostic reagents, medical instruments, and offers extensive support services spanning medical care, nursing assistance, general health support, and clinical examinations. Furthermore, Mitsubishi Chemical Group provides essential industrial materials like basic chemicals, carbon products, synthetic resins, and a variety of industrial gases. Complementing its product offerings, the company's service capabilities are robust, covering engineering, information technology, analysis, inspection, packaging, logistics, surveying, consulting, transportation, and warehousing.
www.mcgc.comNo one on the platform currently holds 4188.T.
No tracked institution reports a position in 4188.T as of their last filing.
No one on the platform has traded 4188.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.4% | 4.6% | 3.7% | — | — | — |
| Rev. Growth % | -16.0% | 2.6% | ||||
| Profit Margin % | 0.3% | 2.1% | 2.7% | |||
| Free Cash Flow Margin % | 4.1% | 3.7% | 4.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $4.03T | +9.2% | $104.93 | $77.92–$133.28 | — | 11 |
| 2028 | $4.07T | +1.1% | $110.74 | $86.88–$135.73 | — | 11 |
| 2029 | $4.17T | +2.4% | $130.57 | $97.30–$155.46 | — | 9 |
| 2030 | $4.46T | +6.9% | $144.25 | $135.00–$154.37 | — | 3 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $17.17 | $42.47 | +147.4% |
| 2026-05-13 | $-38.90 | $-68.07 | -75.0% |
| 2026-02-05 | $10.69 | $-2.96 | -127.7% |
| 2025-10-31 | $72.52 | $65.70 | -9.4% |
| 2025-08-01 | $24.61 | $13.96 | -43.3% |
| 2025-05-13 | $1.93 | $-10.08 | -622.3% |
| 2025-02-06 | $22.41 | $12.96 | -42.2% |
| 2024-11-01 | $5.98 |
| $0.89 |
| -85.1% |
| +0.81% |
| $925.9B |
| — |
| 4021.TNissan Chemical Corporation | $7964.00 | +1.66% | $1.07T | — |
| 4042.TTosoh Corporation | $2561.00 | +0.79% | $788.5B | — |
Source: Financial Modeling Prep · peers by sector/industry